Amgen | A Worldwide Pioneer in Biotechnology

Amgen is a global biotechnology pioneer committed to discovering, developing, and delivering innovative medicines for some of the world’s toughest diseases. Combining biology with advanced technology, the company reaches millions of patients worldwide, helping people live easier, fuller, and longer lives through accessible, life-changing treatments. What sets Amgen apart is its deep expertise in biologics, robust R&D pipeline, and scalable manufacturing, enabling reliable production of high-quality therapies. The company leverages cutting-edge science, including biologics and small molecules, to target complex conditions with precision, offering differentiated solutions that improve patient outcomes and advance global health standards. Amgen’s medicines are used to treat serious illnesses such as cancer, cardiovascular disease, inflammatory disorders, and bone health conditions. Its primary audience includes patients, healthcare providers, researchers, and payers seeking effective, evidence-based treatments. By partnering with medical communities, Amgen supports care across hospitals, clinics, and specialty practices worldwide. Founded in 1980, Amgen has grown into one of the world’s largest independent biotechnology companies, with a strong global footprint and a history of breakthrough therapies. Its commitment to science, quality, and patient access has positioned Amgen as an industry leader shaping the future of medicine.